Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Abstract Data (N = 6844) from National Health and Nutrition Examination Survey for US adults aged ≥ 20 years for the years 2007–2014 were analyzed to evaluate distributional characteristics of selected perfluoroalkyl substances (PFAS) ‐ perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorodecanoic acid (PFDA), perfluorohexane sulfonate (PFHxS) and perfluorononanoic acid (PFNA) with declining glomerular function. The population was stratified according to the estimated glomerular filtration rates (eGFR) that accompany the stages of kidney disease, designated as glomerular function‐1 (GF‐1, eGFR>90 mL/min/1.73 m2); GF‐2 (eGFR 60–89 mL/min/1.73 m2), GF‐3A (eGFR 45–59 mL/min/1.73 m2), and GF‐3B and 4 combined (eGFR 15–44 mL/min/1.73 m2). Unadjusted as well as adjusted geometric means for serum PFOA, PFDA, PFHxS, and PFNA increased as expected through stage GF‐3A but decreased below the concentrations associated with GF‐1 for those who were in GF‐3B/4. For example, unadjusted geometric means for PFOA were 2.59, 3.02, 3.01, and 2.22 ng/mL for GF‐1, GF‐2, GF‐3A, and GF‐3B/4 respectively. Adjusted geometric means for PFOA were 2.34, 2.83, 2.83, and 1.81 ng/mL for GF‐1, GF‐2, GF‐3A, and GF‐3B/4 respectively. Thus, PFAS were found to follow inverted U‐shaped distributions across different stages of glomerular function. For females, decreases in adjusted PFAS serum levels were initiated at GF‐3A, while decreases for males began as early as GF‐2. Usually, females are known to have lower levels of PFAS but when in GF‐3A and GF‐3B/4, females were found to have higher levels of PFAS than males. Thus, inverted U‐shaped curves for males and females intersected between GF‐2 and GF‐3A for PFOA and PFHxS and at GF‐3A for PFOS and PFNA. Associations between PFAS and biomarkers of kidney function may be modified in both magnitude and even in direction as kidney function deteriorates. These findings have implications for studies that evaluate associations between PFAS and disease states that affect kidney function, as well as outcome biomarkers known to be affected by kidney function. HighlightsPFAS follow an inverted U‐shaped distribution across declining stages of glomerular function.Shape of the inverted U‐shaped distributions for PFAS differ by gender.Points of inflection are located at GF‐2 for males and GF‐3A for females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049 · cited 1×
“…balance of actively mediated secretion and reabsorption operating on both sides of renal proximal tubules, in which greater tubular reabsorption in humans, compared to other species, may be responsible for the long serum half-lives of the long chain PFAS (Stanifer et al., 2018; Olsen et al., 2007).”
BackgroundHalf-Lives of PFOS, PFHxS and PFOA after End of Exposure to Contaminated Drinking Water
Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C. H., Tallving, P., & Jakobsson, K. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104651 · Cited by 815
Renal elimination of perfluorocarboxylates (PFCAs)
Han, X., Nabb, D. L., Russell, M. H., Kennedy, G. L., & Rickard, R. W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200363w · Cited by 250
Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review
Stanifer, J. W., Stapleton, H. M., Souma, T., Wittmer, A., Zhao, X., & Boulware, L. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04670418 · Cited by 233
Steenland, K., Tinker, S., Shankar, A., & Ducatman, A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0900940 · Cited by 224
Self-citationWatkins, D. J., Josson, J., Elston, B., Bartell, S. M., Shin, H.-M., Vieira, V. M., Savitz, D. A., Fletcher, T., & Wellenius, G. A. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205838 · Cited by 158
Gomis, M. I., Vestergren, R., MacLeod, M., Mueller, J. F., & Cousins, I. T. (2017) · Environment International · doi:10.1016/j.envint.2017.08.002 · Cited by 85
Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid
Nakagawa, H., Terada, T., Harada, K. H., Hitomi, T., Inoue, K., Inui, K., & Koizumi, A. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00409.x · Cited by 76
Mancini, F. R., Rajaobelina, K., Praud, D., Dow, C., Antignac, J. P., Kvaskoff, M., Severi, G., Bonnet, F., Boutron-Ruault, M.-C., & Fagherazzi, G. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.07.007 · Cited by 55 · cited 1×
“, 2018), and non-linear relationships of PFOA to diabetes diagnoses have been detected (Mancini et al., 2018).”
Background
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Self-citationPFAS Molecules: A Major Concern for the Human Health and the Environment
Panieri, E., Baralic, K., Djukic-Cosic, D., Buha Djordjevic, A., & Saso, L. (2022) · Toxics · doi:10.3390/toxics10020044 · Cited by 651
Blake, B. E., & Fenton, S. E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152565 · Cited by 499
Schulz, K., Silva, M. R., & Klaper, R. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139186 · Cited by 259
Severity of COVID-19 at elevated exposure to perfluorinated alkylates
Grandjean, P., Timmermann, C. A. G., Kruse, M., Nielsen, F., Vinholt, P. J., Boding, L., Heilmann, C., & Mølbak, K. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244815 · Cited by 131
“Renal disease (N0-N2) was treated as a separate covariate due to the possible impact of kidney function on plasma-PFAS concentrations [34].”
Background
Metadata
- Authors
- Jain, R. B., & Ducatman, A.
- Venue
- Environmental Research
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 169
- Pages
- 476-482
- ISSN
- 0013-9351 (ISSN-L)
- OpenAlex
- W2902042019
- Cited by
- 73
- References
- 9
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research. https://app.cochat.ai/papers/10.1016/j.envres.2018.11.033
- The paper
- Jain, R. B., & Ducatman, A. (2019). Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research. Environmental Research. https://doi.org/10.1016/j.envres.2018.11.033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.